The nation of Zimbabwe has declined a substantial American health deal valued at $367m (£272m) spanning five years because of Washington's insistence on confidential information.
This rejection became public following a government memo from December was disclosed, which showed President Emmerson Mnangagwa believed the arrangement was "lopsided".
An official representative has since stated that the US was requesting biological samples for scientific study and commercial purposes but refused to guarantee the resulting advantages from any future treatments.
"We will now turn to the difficult and regrettable process of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had donated more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has urged more dialogue to secure a agreement acceptable to both sides so the nation's vital HIV treatment initiative can be sustained.
Wider Implications
Zimbabwe's decision follows a similar case in Kenya, where a high court halted a similar health funding agreement after legal challenges were raised about the security of citizens' health data.
Since returning to office last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had overseen assistance for the American government, but Trump stated its expenditure was "inefficient" and his administration was seeking direct bilateral agreements to boost transparency and accountability.
Based on reports, Sixteen African countries have to date agreed to these new health pacts, representing over $18.3bn in committed funds.
Details of the Rejected Deal
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million presently receiving antiretroviral therapy via American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data indefinitely, without any equivalent guarantee of benefiting from any scientific breakthroughs – such as new medicines or tests – that might be developed from that shared data," he stated.
"Effectively, our country would supply the basic resources for scientific discovery without any assurance that the end products would be accessible to our citizens should a future health crisis emerge."
Sovereignty and Global Health
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining frameworks already established through the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to manage potential global health emergencies.
"This framework is intended to guarantee that when a country contributes its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the capability to develop them."
These objections over the US deal "are not meant as hostility towards the US," he added.
"We are open to further discussions with our US partners on how subsequent co-operation might be designed in a way that respects the sovereignty and dignity of both nations."
Medical Community Reaction
A leading public health body stated it acknowledged the official position, but suggested that talks should continue since much of the country's HIV programmes depended on foreign aid.
"In cases where specific concerns arise, including those relating to data governance or agreement terms, these can frequently be addressed via technical clarification and negotiated safeguards," it commented.
This impasse underscores the complex challenges between accepting vital international aid and protecting local interests in an ever more data-driven world.